We found that PD-L1 is secreted on exosomes in an ALIX-dependent manner, and impaired exosomal release conferred an enhanced immunosuppressive phenotype on tumor cells that was dependent upon EGFR kinase activity. Here, PDCD6IP is linked to neoplasm.